This inventor holds 10 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Bio-Rad Laboratories, Inc., The J. David Gladstone Institutes, Leland Stanford Junior University. Active years: 2006-2026.
Location History:
- Hercules, CA (US) (2020)
- Palo Alto, CA (US) (2006 - 2024)
Company Filing History:
8 out of 1,070 
3 out of 91 
2 out of 5,509 
Years Active: 2006-2026
Title: The Innovative Mind of George Karlin-Neumann
Introduction
George Karlin-Neumann is an accomplished inventor based in Palo Alto, California, known for her significant contributions to the field of biotechnology. With a remarkable portfolio that includes nine patents, she has made notable advancements, particularly in the area of polymerase chain reaction techniques and amplification methods.
Latest Patents
Among her most recent innovations is the patent titled "MDA using bead oligonucleotide," which provides improved multiple displacement amplification (MDA) reagents and methods. This advancement stands out as a critical contribution to enhancing the efficiency and effectiveness of DNA amplification techniques.
Career Highlights
Throughout her career, George Karlin-Neumann has had the opportunity to work with leading organizations, including Bio-Rad Laboratories, Inc. and Leland Stanford Junior University. Her roles in these esteemed institutions have enabled her to push the boundaries of research and development in the biotechnology sector.
Collaborations
In her pursuit of innovation, George has collaborated with notable colleagues, including Ronald Lebofsky and Jeremy Agresti. These partnerships have not only enriched her research endeavors but have also fostered an environment of creativity and idea exchange, leading to impactful scientific progress.
Conclusion
George Karlin-Neumann exemplifies the essence of innovation in biotechnology. Her dedication to improving scientific techniques through her inventive work continues to inspire her peers and the next generation of scientists. With an impressive track record and ongoing contributions, she remains a significant figure in the field of biotechnology and a role model for aspiring inventors.